Pefloxacin Mesylate Dihydrate
CAS No. 149676-40-4
Pefloxacin Mesylate Dihydrate( Pefloxacin Mesylate Dihydrate; Pefloxacin (mesylate dihydrate); Peflacin )
Catalog No. M12077 CAS No. 149676-40-4
Pefloxacin mesylate dehydrate is a an antibacterial agent and prevents bacterial DNA replication by inhibiting DNA gyrase (topoisomerse).
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100mg | 113 | In stock |
|
50mg | 76 | In stock |
|
25mg | 51 | In stock |
|
Biological Information
-
Product NamePefloxacin Mesylate Dihydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionPefloxacin mesylate dehydrate is a an antibacterial agent and prevents bacterial DNA replication by inhibiting DNA gyrase (topoisomerse).
-
DescriptionPefloxacin mesylate dehydrate is a an antibacterial agent and prevents bacterial DNA replication by inhibiting DNA gyrase (topoisomerse).
-
SynonymsPefloxacin Mesylate Dihydrate; Pefloxacin (mesylate dihydrate); Peflacin
-
PathwayCell Cycle/DNA Damage
-
TargetTopoisomerase
-
RecptorTopo II
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number149676-40-4
-
Formula Weight465.49
-
Molecular FormulaC17H20FN3O3·CH4O3S·2H2O
-
Purity>98%(HPLC)
-
SolubilityWater: 67 mg/mL (143.93 mM); DMSO: 9 mg/mL (19.33 mM)
-
SMILESCCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O.CS(=O)(=O)O.O.O
-
Chemical Name1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid;methanesulfonic acid;dihydrate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bergogne-Bérézin E, et al. Int J Antimicrob Agents. 1991;1(1):29-46.
molnova catalog
related products
-
Mitoxantrone hydroch...
Mitoxantrone Dihydrochloride, a type II topoisomerase inhibitor, is an anthracenedione-derived antineoplastic agent.
-
Wogonoside
Wogonoside acts as apositive allosteric modulatorof thebenzodiazepine site of theGABAAreceptor.
-
SN-38
LE-SN38 is NeoPharm’s NeoLipid liposomal formulation of SN-38, the active metabolite of irinotecan (Camptosar), a chemotherapeutic pro-drug approved for the treatment of advanced colorectal Y.